User Settings
Article

[Treatment of small cell lung cancer: limited disease. Guidelines of clinical practice made by the European Lung Cancer Working Party].

Stéphane Holbrechts,Marcel Roelandts-2014-10-10-PubMed
1

TL;DRAbstract

These updated clinical practice guidelines on the treatment of small cell lung cancer (SCLC) limited disease formulated by the ELCWP aim to answer the following questions: 1) What is the definition of limited disease? 2) Is thoracic irradiation needed and what are the benefits? 3) What is the optimal time and method of chest irradiation? 4) What are the optimal parameters of irradiation : dose, fractionation, target volume? 5) When radiochemotherapy is not possible at the outset, how should consider radiotherapy after induction chemotherapy ? 6) What is the optimal chemotherapy for limited stage SCLC? 7) Should preventive brain irradiation be given and if so, when and to which patients? 8) What is the complementary role of thoracic surgery in early SCLC?

Chat with Paper

AI Agents for this Paper

These updated clinical practice guidelines on the treatment of small cell lung cancer (SCLC) limited disease formulated by the ELCWP aim to answer the following questions: 1) What is the definition of limited disease? 2) Is thoracic irradiation needed and what are the benefits? 3) What is the optimal time and method of chest irradiation? 4) What are the optimal parameters of irradiation : dose, fractionation, target volume? 5) When radiochemotherapy is not possible at the outset, how should consider radiotherapy after induction chemotherapy ? 6) What is the optimal chemotherapy for limited stage SCLC? 7) Should preventive brain irradiation be given and if so, when and to which patients? 8) What is the complementary role of thoracic surgery in early SCLC?

Keywords

MedicineRadiation therapyLung cancerProphylactic cranial irradiationDiseaseChemotherapyClinical PracticeStage (stratigraphy)

Chat

Click to start Chat